These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10506608)

  • 1. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
    Rowlings PA; Curtis RE; Passweg JR; Deeg HJ; Socié G; Travis LB; Kingma DW; Jaffe ES; Sobocinski KA; Horowitz MM
    J Clin Oncol; 1999 Oct; 17(10):3122-7. PubMed ID: 10506608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
    J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
    Baker KS; DeFor TE; Burns LJ; Ramsay NK; Neglia JP; Robison LL
    J Clin Oncol; 2003 Apr; 21(7):1352-8. PubMed ID: 12663726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
    Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML
    Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.
    Alexander FE; Jarrett RF; Lawrence D; Armstrong AA; Freeland J; Gokhale DA; Kane E; Taylor GM; Wright DH; Cartwright RA
    Br J Cancer; 2000 Mar; 82(5):1117-21. PubMed ID: 10737396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant neoplasms following bone marrow transplantation.
    Bhatia S; Ramsay NK; Steinbuch M; Dusenbery KE; Shapiro RS; Weisdorf DJ; Robison LL; Miller JS; Neglia JP
    Blood; 1996 May; 87(9):3633-9. PubMed ID: 8611687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus in Hodgkin's disease patients in Japan.
    Tomita Y; Ohsawa M; Kanno H; Hashimoto M; Ohnishi A; Nakanishi H; Aozasa K
    Cancer; 1996 Jan; 77(1):186-92. PubMed ID: 8630928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
    Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN; Chhanabhai M; Gascoyne RD; Shepherd JD; Fung HC; Nantel SH; Toze CL; Klingemann HG; Sutherland HJ; Hogge DE; Nevill TJ; Le A; Barnett MJ
    Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
    Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
    Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
    Almasri NM; Khalidi HS
    Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease after transplantation.
    Garnier JL; Lebranchu Y; Dantal J; Bedrossian J; Cahen R; Assouline D; Jaccard A; Fetissoff F; Moreau A; Martin X; Delsol G; Berger F; Touraine JL
    Transplantation; 1996 Jan; 61(1):71-6. PubMed ID: 8560577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
    Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
    Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.